Renalytix repays $1.06M of convertible bond with shares and ADSs

Renalytix plc

Issued 2.275M ordinary shares and 4.641M ADSs to settle $1.06M principal and interest due July 7, 2024.
Remaining convertible bond principal reduced to $11.66M from $12.72M.
Shares issued under Section 3(a)(9) exemption; no registration.
11.56M new ordinary shares to be admitted to AIM on July 17, 2024.
Post-Admission total ordinary shares: 165,925,513; each ADS represents two ordinary shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.